| ASSET | YEAR | % RETURN |
|---|---|---|
Erasca (ERAS) | 2026 | 231.27% |
Immunitybio (IBRX) | 2026 | 199.5% |
Alumis (ALMS) | 2026 | 168.07% |
Powell Industries (POWL) | 2026 | 80.31% |
USA Rare Earth (USAR) | 2026 | 77.85% |
Liberty Global PLC Class B (LBTYB) | 2026 | 56.61% |
FormFactor (FORM) | 2026 | 56.08% |
Neogen (NEOG) | 2026 | 55.84% |
Silicon Laboratories (SLAB) | 2026 | 55.47% |
Twist Bioscience (TWST) | 2026 | 55.18% |
Enphase Energy (ENPH) | 2026 | 54.42% |
Allegro Microsystems (ALGM) | 2026 | 53.96% |
Chemours (CC) | 2026 | 53.31% |
Acm Research (ACMR) | 2026 | 52.39% |
Kulicke and Soffa Industries (KLIC) | 2026 | 51.51% |
ArcBest (ARCB) | 2026 | 50.79% |
IPG Photonics (IPGP) | 2026 | 50.42% |
Brookdale Senior Living (BKD) | 2026 | 50.37% |
Under Armour Inc C (UA) | 2026 | 48.58% |
Under Armour Inc A (UAA) | 2026 | 46.51% |
Viavi Solutions (VIAV) | 2026 | 46.15% |
Energy Fuels (UUUU) | 2026 | 44.75% |
Vicor (VICR) | 2026 | 43.43% |
Arrow Electronics (ARW) | 2026 | 42.64% |
Phibro Animal Health (PAHC) | 2026 | 41.29% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
